Market Trends J&J gets positive EU opinion for subcutaneous Rybrevant (HALO:NASDAQ)By admin8996erT0allFebruary 3, 2025 Sundry PhotographyEU regulators have issued a positive opinion for the extension of the market authorization for a subcutaneous formulation of…
Market Trends Sanofi reports positive results for subcutaneous Sarclisa (SNY:NASDAQ)By admin8996erT0allJanuary 9, 2025 Panama7Sanofi (NASDAQ:SNY) said that a Phase 3 study of its new subcutaneous formulation of Sarclisa in the treatment of multiple…
